Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-1849.39%
operating margin TTM
-1850.1%
revenue TTM
551.94 Billion
revenue per share TTM
30493.18$
valuation ratios | |
|---|---|
| pe ratio | -1.09 |
| peg ratio | 0.08 |
| price to book ratio | 2.24 |
| price to sales ratio | 19.98 |
| enterprise value multiple | -1.48 |
| price fair value | 2.24 |
profitability ratios | |
|---|---|
| gross profit margin | 99.56% |
| operating profit margin | -1850.1% |
| pretax profit margin | -1849.92% |
| net profit margin | -1849.39% |
| return on assets | -168.97% |
| return on equity | -149.35% |
| return on capital employed | -216.92% |
liquidity ratios | |
|---|---|
| current ratio | 3.90 |
| quick ratio | 3.90 |
| cash ratio | 3.09 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 212.23 |
| days of payables outstanding | 194,162.42 |
| cash conversion cycle | -193,950.19 |
| receivables turnover | 1.72 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.02 |
| debt equity ratio | 0.02 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.02 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -83.20 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.53 |
| cash per share | 0.25 |
| operating cash flow per share | -0.53 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -83.20 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -102.93 |
Frequently Asked Questions
When was the last time Lexaria Bioscience Corp. (NASDAQ:LEXX) reported earnings?
Lexaria Bioscience Corp. (LEXX) published its most recent earnings results on 14-07-2025.
What is Lexaria Bioscience Corp.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Lexaria Bioscience Corp. (NASDAQ:LEXX)'s trailing twelve months ROE is -149.35%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Lexaria Bioscience Corp. (LEXX) currently has a ROA of -168.97%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did LEXX's net profit margin stand at?
LEXX reported a profit margin of -1849.39% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is LEXX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.90 in the most recent quarter. The quick ratio stood at 3.90, with a Debt/Eq ratio of 0.02.